Switching to biosimilars could save £1bn over five years, says NHS England
Switching from original biologic to biosimilar medicines could save the NHS £1bn over five years, NHS England has told The Pharmaceutical Journal. On 31 January 2025, NHS England published its ‘2025/2026 priorities and operational planning guidance’ for NHS trusts and integrated care boards. The guidance, which includes a priority to exhaust “all possible realistic in-year […]
Continue reading this article about Switching to biosimilars could save £1bn over five years, says NHS England
by The Pharmaceutical Journal
NHS Forums - For daily discussion by NHS Staff.

Switching from original biologic to biosimilar medicines could save the NHS £1bn over five years, NHS England has told The Pharmaceutical Journal. On 31 January 2025, NHS England published its ‘2025/2026 priorities and operational planning guidance’ for NHS trusts and integrated care boards. The guidance, which includes a priority to exhaust “all possible realistic in-year […]
Continue reading this article about Switching to biosimilars could save £1bn over five years, says NHS England
by The Pharmaceutical Journal
NHS Forums - For daily discussion by NHS Staff.